{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:59:13Z","timestamp":1758815953301},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,7,5]],"date-time":"2020-07-05T00:00:00Z","timestamp":1593907200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,5]],"date-time":"2020-07-05T00:00:00Z","timestamp":1593907200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s10875-020-00795-6","type":"journal-article","created":{"date-parts":[[2020,7,5]],"date-time":"2020-07-05T05:03:03Z","timestamp":1593925383000},"page":"893-900","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Haploidentical Hematopoietic Stem Cell Transplantation for XIAP Deficiency: a Single-Center Report"],"prefix":"10.1007","volume":"40","author":[{"given":"Jun","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang-Hua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Guang","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Hao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mao-Quan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,5]]},"reference":[{"issue":"2","key":"795_CR1","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0165-4608(91)90127-G","volume":"51","author":"DT Purtilo","year":"1991","unstructured":"Purtilo DT, Grierson HL. Methods of detection of new families with X-linked lymphoproliferative disease. Cancer Genet Cytogenet. 1991;51(2):143\u201353.","journal-title":"Cancer Genet Cytogenet"},{"key":"795_CR2","first-page":"3118","volume":"96","author":"J Sumegi","year":"2000","unstructured":"Sumegi J, Huang D, Lanyi A, Davis JD, Seemayer TA, Maeda A, et al. Correlation of mutations of the SH2D1A gene and Epstein\u2013Barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease. Blood. 2000;96:3118\u201325.","journal-title":"Blood."},{"key":"795_CR3","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s10875-011-9638-z","volume":"32","author":"Y Xi","year":"2012","unstructured":"Xi Y, Hirokazu K, Naonori N, Toshihiko I, Kazuko H, Ritsuko M, et al. Clinical and genetic characteristics of XIAP deficiency in Japan. J Clin Immunol. 2012;32:411\u201320.","journal-title":"J Clin Immunol"},{"key":"795_CR4","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/sj.embor.7400795","volume":"7","author":"BP Eckelman","year":"2006","unstructured":"Eckelman BP, Salvesen GS, Scott FL. Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. EMBO Rep. 2006;7:988\u201394.","journal-title":"EMBO Rep"},{"key":"795_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1365-2141.2010.08442.x","volume":"152","author":"N Rezaei","year":"2011","unstructured":"Rezaei N, Mahmoudi E, Aghamohammadi A, Das R, Nichols KE. X-linked lymph.oproliferative syndrome: a genetic condition typified by the triad of infection, immunodeficiency and lymphoma. Br J Haematol. 2011;152:13\u201330.","journal-title":"Br J Haematol"},{"key":"795_CR6","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/GIM.0b013e3182088158","volume":"13","author":"EA Worthey","year":"2011","unstructured":"Worthey EA, Mayer AN, Syverson GD, Helbling D, Bonacci BB, Decker B, et al. Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genet Med. 2011;13:255\u201362.","journal-title":"Genet Med"},{"key":"795_CR7","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nature11582","volume":"491","author":"L Jostins","year":"2012","unstructured":"Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491:119\u201324.","journal-title":"Nature."},{"key":"795_CR8","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1182\/blood-2012-06-432500","volume":"121","author":"RA Marsh","year":"2013","unstructured":"Marsh RA, Rao K, Satwani P, Lehmberg K, M\u00fcller I, Li D, et al. Allogeneic hematopoietic cell transplantation for XIAP deficiency:an international survey reveals poor outcomes. Blood. 2013;121:877\u201383.","journal-title":"Blood."},{"issue":"1","key":"795_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s10875-016-0348-4","volume":"37","author":"S Ono","year":"2017","unstructured":"Ono S, Okano T, Hoshino A, Yanagimachi M, Hamamoto K, Nakazawa Y, et al. Hematopoietic stem cell transplantation for XIAP deficiency in Japan. J Clin Immunol. 2017;37(1):85\u201391.","journal-title":"J Clin Immunol"},{"issue":"6","key":"795_CR10","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s10875-017-0413-7","volume":"37","author":"C O'Rafferty","year":"2017","unstructured":"O'Rafferty C, Velangi M, Lawson S, Hiwarkar P, Motwani J. IFN\u0263 block, treosulfan conditioning and \u03b1\u03b2 T cell deplete PBSCT for XIAP-deficient HLH. J Clin Immunol. 2017;37(6):511\u20133.","journal-title":"J Clin Immunol"},{"issue":"3","key":"795_CR11","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.3892\/etm.2016.3498","volume":"12","author":"MY Jiang","year":"2016","unstructured":"Jiang MY, Guo X, Sun SW, Li Q, Zhu YP. Successful allogeneic hematopoietic stem cell transplantation in a boy with X-linked inhibitor of apoptosis deficiency presenting with hemophagocytic lymphohistiocytosis: a case report. Exp Ther Med. 2016;12(3):1341\u20134.","journal-title":"Exp Ther Med"},{"issue":"4","key":"795_CR12","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/ped4.12096","volume":"2","author":"J Chenguang","year":"2018","unstructured":"Chenguang J, Bin W, Guanghua Z, Rui Z, Kai W, Yan Y, et al. Haploidentical hematopoietic stem cell transplantation using reduced-intensity conditioning for pediatric patients with familial hemophagocytic lymphohistiocytosis. Pediatr Invest. 2018;2(4):216\u201321.","journal-title":"Pediatr Invest"},{"key":"795_CR13","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Aric\u00f3 M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohis -tiocytosis. Pediatr Blood Cancer. 2007;48:124\u201331.","journal-title":"Pediatr Blood Cancer"},{"issue":"25","key":"795_CR14","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1182\/blood-2017-06-788349","volume":"130","author":"E Bergsten","year":"2017","unstructured":"Bergsten E, Horne A, Aric\u00f3 M, Astigarraga I, Egeler RM, Filipovich AH, et al. Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study. Blood. 2017;130(25):2728\u201338.","journal-title":"Blood."},{"issue":"3","key":"795_CR15","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","volume":"15","author":"S Giralt","year":"2009","unstructured":"Giralt S, Ballen K, Rizzo D, Bacigalupo A, Horowitz M, Pasquini M, et al. Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. Biol Blood Marrow Transplant. 2009;15(3):367\u20139.","journal-title":"Biol Blood Marrow Transplant"},{"key":"795_CR16","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/bmt.2011.140","volume":"47","author":"AA Hamidieh","year":"2012","unstructured":"Hamidieh AA, Pourpak Z, Hosseinzadeh M, Fazlollahi MR, Alimoghaddam K, Movahedi M, et al. Reduced-intensity conditioning hematopoietic SCT for pediatric patients with LAD-1: clinical efficacy and importance of chimerism. Bone Marrow Transplant. 2012;47:646\u201350.","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"795_CR17","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1038\/leu.2015.75","volume":"29","author":"RF Olsson","year":"2015","unstructured":"Olsson RF, Logan BR, Chaudhury S, Zhu X, Akpek G, Bolwell BJ, et al. Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies. Leukemia. 2015;29(8):1754\u201362.","journal-title":"Leukemia"},{"key":"795_CR18","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.1182\/blood-2005-08-3374","volume":"107","author":"K Leischhauer","year":"2006","unstructured":"Leischhauer K, Locatelli F, Zecca M, Orofino MG, Giardini C, De Stefano P, et al. Graft rejection after unrelated donor hematopoietic stem cell transplantation for thalassemia is associated with nonpermissive HLA-DPB1 disparity in host-versus graft direction. Blood. 2006;107:2984\u201392.","journal-title":"Blood"},{"key":"795_CR19","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. 1994 consensus conference on acute GVHD grading. Bone Marrow Transplant. 1995;15:825\u20138.","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"795_CR20","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/j.bbmt.2015.05.004","volume":"21","author":"PJ Martin","year":"2015","unstructured":"Martin PJ, Lee SJ, Przepiorka D, Horowitz MM, Koreth J, Vogelsang GB, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: VI. The 2014 Clinical Trial Design Working Group Report. Biol Blood Marrow Transplant. 2015;21(8):1343\u201359.","journal-title":"Biol Blood Marrow Transplant"},{"key":"795_CR21","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.jaci.2010.11.040","volume":"127","author":"PC Horn","year":"2011","unstructured":"Horn PC, Belohradsky BH, Urban C, Weber-Mzell D, Meindl A, Schuster V. Two new families with Xlinked inhibitor of apoptosis deficiency and a review of all 26 published cases. J Allergy Clin Immunol. 2011;127:544\u20136.","journal-title":"J Allergy Clin Immunol"},{"key":"795_CR22","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.1038\/sj.onc.1202569","volume":"17","author":"EC LaCasse","year":"1998","unstructured":"LaCasse EC, Baird S, Korneluk RG, MacKenzie AE. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene. 1998;17:3247\u201359.","journal-title":"Oncogene"},{"key":"795_CR23","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.it.2012.06.004","volume":"33","author":"ST Beug","year":"2012","unstructured":"Beug ST, Cheung HH, LaCasse EC, Korneluk RG. Modulation of immune signalling by inhibitors of apoptosis. Trends Immunol. 2012;33:535\u201345.","journal-title":"Trends Immunol"},{"key":"795_CR24","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.molmed.2014.09.006","volume":"20","author":"J Pedersen","year":"2014","unstructured":"Pedersen J, LaCasse EC, Seidelin JB, Coskun M, Nielsen OH. Inhibitors of apoptosis (IAPs) regulate intestinal immunity and inflammatory bowel disease (IBD) inflammation. Trends Mol Med. 2014;20:652\u201365.","journal-title":"Trends Mol Med"},{"issue":"10","key":"795_CR25","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/s41419-019-1938-x","volume":"10","author":"K Janin","year":"2019","unstructured":"Janin K, Lisanne MS, Stefanie R, Ramona R, Lazaros V, Monica Y, et al. TNFR2 induced priming of the inflammasome leads to a RIPK1-dependent cell death in the absence of XIAP. Cell Death Dis. 2019;10(10):700.","journal-title":"Cell Death Dis"},{"key":"795_CR26","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.canlet.2012.06.015","volume":"332","author":"EC LaCasse","year":"2013","unstructured":"LaCasse EC. Pulling the plug on a cancer cell by eliminating XIAP with AEG35156. Cancer Lett. 2013;332:215\u201324.","journal-title":"Cancer Lett"},{"issue":"3","key":"795_CR27","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/cei.12306","volume":"176","author":"S Ammann","year":"2014","unstructured":"Ammann S, Elling R, Gyrd-Hansen M, D\u00fcckers G, Bredius R, Burns SO, et al. A new functional assay for the diagnosis of X-linked inhibitor of apoptosis (XIAP) deficiency. Clin Exp Immunol. 2014;176(3):394\u2013400.","journal-title":"Clin Exp Immunol"},{"key":"795_CR28","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.jaci.2014.04.031","volume":"134","author":"C Aguilar","year":"2014","unstructured":"Aguilar C, Lenoir C, Lambert N, B\u00e8gue B, Brousse N, Canioni D, et al. Characterization of Crohn disease in X-linked inhibitor of apoptosis-deficient male patients and female symptomatic carriers. J Allergy Clin Immunol. 2014;134:1131\u201341.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"795_CR29","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s10875-015-0166-0","volume":"35","author":"M Dziadzio","year":"2015","unstructured":"Dziadzio M, Ammann S, Canning C, Boyle F, Hassan A, Cale C, et al. Symptomatic males and female carriers in a large Caucasian kindred with XIAP deficiency. J Clin Immunol. 2015;35(5):439\u201344.","journal-title":"J Clin Immunol"},{"key":"795_CR30","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10875-015-0141-9","volume":"35","author":"C Aguilar","year":"2015","unstructured":"Aguilar C, Latour S. X-linked inhibitor of apoptosis protein deficiency: more than an X-linked lymphoproliferative syndrome. J Clin Immunol. 2015;35:331\u20138.","journal-title":"J Clin Immunol"},{"issue":"9","key":"795_CR31","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1007\/s00277-017-3056-0","volume":"96","author":"LR Eucario","year":"2017","unstructured":"Eucario LR, Monica MRF, Sandra IPA. Reduced BUCY 2 and G-CSF-primed bone marrow associateswith low graft-versus-host-disease and transplant-relatedmortality in allogeneic HSCT. Ann Hematol. 2017;96(9):1525\u201331.","journal-title":"Ann Hematol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-020-00795-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-020-00795-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-020-00795-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T19:16:07Z","timestamp":1599246967000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-020-00795-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,5]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["795"],"URL":"https:\/\/doi.org\/10.1007\/s10875-020-00795-6","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,5]]},"assertion":[{"value":"13 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}